Cholesterol biosynthesis

Biochemistry of Lipids, Lipoproteins and Membranes

Volumn , Issue , 2008, Pages 399-421

  Liscum, Laura ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882461364     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044453219-0.50016-7     Document Type: Chapter

References (29)

1. Ikonen E. Mechanisms for cellular cholesterol transport: defects and human disease. Physiol. Rev. 2006, 86:1237-1261.
2. Horton J.D., Goldstein J.L., Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 2002, 109:1125-1131.
3. Dietschy J.M., Turley S.D. Cholesterol metabolism in the brain. Curr. Opin. Lipidol. 2001, 12:105-112.
4. Olivier L.M., Krisans S.K. Peroxisomal protein targeting and identification of peroxisomal targeting signals in cholesterol biosynthetic enzymes. Biochim. Biophys. Acta 2000, 1529:89-102.
5. Gotto A.M., LaRosa J.C. The benefits of statin therapy - what questions remain?. Clin Cardiol. 2005, 28:499-503.
6. Tansey T.R., Shechter I. Structure and regulation of mammalian squalene synthase. Biochim. Biophys. Acta 2000, 1529:49-62.
7. Waterham H.R., Wanders R.J. Biochemical and genetic aspects of 7-dehydrocholesterol reductase and Smith-Lemli-Opitz syndrome. Biochim. Biophys. Acta 2000, 1529:340-356.
8. Herman G.E. Disorders of cholesterol biosynthesis: prototypic metabolic malformation syndromes. Hum. Mol. Genet. 2003, 12(Spec. No. 1):R75-R88.
9. Kelley R.I., Herman G.E. Inborn errors of sterol biosynthesis. Annu. Rev. Genomics Hum. Genet. 2001, 2:299-341.
10. Sweetman L., Williams J.C. Branched chain organic acidurias. The Metabolic and Molecular Bases of Inherited Disease 2001, 2125-2163. McGraw-Hill, New York. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
11. Kelley R.I., Hennekam R.C.M. Smith-Lemli-Opitz syndrome. The Metabolic and Molecular Bases of Inherited Disease 2001, 6183-6201. McGraw-Hill, New York. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
12. Yu H., Patel S.B. Recent insights into the Smith-Lemli-Opitz syndrome. Clin. Genet. 2005, 68:383-391.
13. Woollett L.A. The origins and roles of cholesterol and fatty acids in the fetus. Curr. Opin. Lipidol. 2001, 12:305-312.
14. Goldstein J.L., DeBose-Boyd R.A., Brown M.S. Protein sensors for membrane sterols. Cell 2006, 124:35-46.
15. Chang T.Y., Hasan M.T., Chin J., Chang C.C., Spillane D.M., Chen J. Chinese hamster ovary cell mutants affecting cholesterol metabolism. Curr. Opin. Lipidol. 1997, 8:65-71.
16. Goldstein J.L., Rawson R.B., Brown M.S. Mutant mammalian cells as tools to delineate the sterol regulatory element-binding protein pathway for feedback regulation of lipid synthesis. Arch. Biochem. Biophys. 2002, 397:139-148.
17. Brown M.S., Goldstein J.L. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:11041-11048.
18. Rawson R.B. The SREBP pathway - insights from Insigs and insects. Nat. Rev. Mol. Cell Biol. 2003, 4:631-640.
19. Hampton R.Y. Proteolysis and sterol regulation. Annu. Rev. Cell Dev. Biol. 2002, 18:345-378.
20. Chang T.Y., Chang C.C., Ohgami N., Yamauchi Y. Cholesterol sensing, trafficking, and esterification. Annu. Rev. Cell Dev. Biol. 2006, 22:129-157.
21. Patterson M.C., Vanier M.T., Suzuki K., Morris J.A., Carstea E., Neufeld E.B., Blanchette-Mackie J.E., Pentchev P.G. Niemann-Pick disease type C: a lipid trafficking disorder. The Metabolic and Molecular Bases of Inherited Disease 2001, 3611-3633. McGraw-Hill, New York. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
22. Huff M.W., Pollex R.L., Hegele R.A. NPC1L1: evolution from pharmacological target to physiological sterol transporter. Arterioscler. Thromb. Vase. Biol. 2006, 26:2433-2438.
23. Olkkonen V.M. Oxysterol binding protein and its homologues: new regulatory factors involved in lipid metabolism. Curr. Opin. Lipidol. 2004, 15:321-327.
24. Massey J.B. Membrane and protein interactions of oxy sterols. Curr. Opin. Lipidol. 2006, 17:296-301.
25. Russell D.W. Oxysterol biosynthetic enzymes. Biochim. Biophys. Acta 2000, 1529:126-135.
26. Bjorkhem L., Boberg K.M., Leitersdorf E. Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol. The Metabolic and Molecular Bases of Inherited Disease 2001, 2961-2988. McGraw-Hill, New York. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
27. Bjorkhem I. Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J. Intern. Med. 2006, 260:493-508.
28. Geyeregger R., Zeyda M., Stulnig T.M. Liver X receptors in cardiovascular and metabolic disease. Cell. Mol. Life Sci. 2006, 63:524-539.
29. Chang T.Y., Chang C.C., Lin S., Yu C., Li B.L., Miyazaki A. Roles of acyl-coenzyme Axholesterol acyltransferase-1 and -2. Curr. Opin. Lipidol. 2001, 12:289-296.